Left Menu
Development News Edition

Next-Generation Sequencing (NGS) Market expected to grow at 19.2 pct by 2024

PR Newswire | Pune | Updated: 14-06-2019 15:56 IST | Created: 14-06-2019 15:38 IST
Next-Generation Sequencing (NGS) Market expected to grow at 19.2 pct by 2024
Image Credit: Pixabay

The Global Next-Generation Sequencing Market is projected to reach US$ 16.35 Billion by 2024 from US$ 5.70 Billion in 2018, at a CAGR of 19.2%. Factors such as advancements in NGS platforms, declining NGS capital cost coupled with decreasing cost of sequencing, improving regulatory & reimbursement scenario for NGS-based diagnostic tests, initiatives from government & private bodies for large-scale sequencing projects, and increasing application of NGS in precision medicine & molecular diagnostics are expected to propel the growth of this market.

Major vendors in the global Next-Generation Sequencing (NGS) Market include Illumina, Inc. (US), Thermo Fisher Scientific, Inc. (US), Pacific Biosciences of California, Inc. (US), BGI (China), PerkinElmer (US), Agilent Technologies (US), QIAGEN N. V. (Germany), Macrogen Inc. (South Korea), Oxford Nanopore Technologies, Ltd. (UK), and Eurofins Scientific (Luxembourg).

"Sequencing by Synthesis Segment to Dominate the NGS Market, by Technology, in 2018"

The Next-Generation Sequencing Market, by technology, is segmented into sequencing by synthesis, ion semiconductor sequencing, single-molecule real-time sequencing, nanopore sequencing, and other sequencing technologies. The sequencing by synthesis segment is expected to command the largest share of the next-generation sequencing market in 2018.

"Hospitals & Clinics Segment to Register the Highest CAGR During 2018–2024"

On the Basis of End User, the next-generation sequencing market is segmented into academic institutes & research centers, hospitals & clinics, pharmaceutical & biotechnology companies, and other end users. The hospitals & clinics segment is estimated to witness the highest growth rate during the forecast period.

"The NGS Market in the APAC is projected to Witness the Highest Growth Rate During the Forecast Period"

The Next-Generation Sequencing Market in the Asia Pacific is expected to witness the highest CAGR from 2018 to 2024. Factors such as increasing financial support from public as well as private agencies for NGS based research and diagnostics, increasing number of NGS-based research projects, increasing awareness about precision medicine, and high incidence of chronic diseases in the region are driving the growth of the next-generation sequencing market in the APAC region.


TRENDING

OPINION / BLOG / INTERVIEW

Why COVID-19 is unstoppable in USA despite it being ranked at the top of GHS Index?

Several worst-hit countries such as Italy, France, Spain, the UK, Canada, and Russia have peaked COVID-19 cases in April. Almost all of them have gradually flattened the curve. However, the USA is setting new daily records of infections tha...

COVID-19 seems cooking biggest ever global scam

The increasing number of corruption cases on COVID-19 funds from throughout the world and involvement of high profile persons indicate that the countries cant ignore corruption in their pandemic response programs. This has generated the nee...

Health Management Information Systems lack holistic, integrated, and pandemic resilient character

Being a part of the United Nations system, the World Health Organization WHO deserves its share of rebuke for its alleged failure issue COVID-19 health emergency alerts on appropriate time. However, the pandemic has also exposed loopholes i...

Pride in the time of coronavirus: a welcome move online?

This year is different in many ways not least as celebrations are also taking place against the dramatic backdrop of a global health crisis and a resurgence in grassroots activism following the death of George Floyd in Minneapolis. ...

Videos

Latest News

As virus rages in US, New York guards against another rise

As coronavirus rages out of control in other parts of the US, New York is offering an example after taming the nations deadliest outbreak this spring while also trying to prepare in case another surge comes. New Yorks early experience is a...

Early detection of COVID-19 cases has resulted in low fatality rate of 2.66 pc: Vardhan

Early detection of COVID-19 cases through widespread testing, surveillance and clinical management has resulted in India having one of the lowest fatality rate at 2.66 per cent, Union Health Minister Harsh Vardhan said on Sunday. The minist...

Make U.S. schools reopening guidelines mandatory -Pelosi

The federal health guidelines on how U.S. schools can safely reopen amid the coronavirus outbreak - criticized by President Donald Trump as too tough - should be mandatory, House Speaker Nancy Pelosi said on Sunday. The Democratic House of ...

COVID-19: Schwing Shetter expects 15 pc decline in sales this fiscal

German concreting and construction equipment maker Schwing Shetter is expecting 15 per cent decline in sales in India business this fiscal, mainly due to COVID-19 pandemic, a top company official has said. The company, which follows the cal...

Give Feedback